<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Arbutus Biopharma Corporation

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Arbutus Biopharma Corporation

    Arbutus Biopharma is a publicly-traded (NASDAQ:ABUS) biopharmaceutical company dedicated to discovering, developing and commercializing a cure for patients suffering from chronic hepatitis B infection, a disease of the liver caused by hepatitis B virus (HBV). We are developing a portfolio of drug candidates with multiple mechanisms of action that we believe will result in a combination therapy that will transform the HBV treatment landscape and cure hepatitis B virus disease. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      William H. Collier
    • FOUNDED
      1992
    • EMPLOYEES
      51-100
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Hera Health Solutions, Inc.

    Hera Health Solutions, Inc.

    Hera Health Solutions is a pharmaceutical device company based in Memphis, Tenness...

    Hera Health Solutions is a pharmaceutical devic...

    Amount Raised:    $256,955.00
    Fundraising Status:    SD
    Filing Type:    CF
    MicroGen Vet LLC

    MicroGen Vet LLC

    The next evolution in DNA-based diagnostics. MicroGen Vet is the exclusive reselle...

    The next evolution in DNA-based diagnostics. Mi...

    Amount Raised:    $51,390.00
    Fundraising Status:    EC
    Filing Type:    CF
    TrovaGene, Inc.

    TrovaGene, Inc.

    Trovagene is a clinical-stage, oncology therapeutics company, taking a precision m...

    Trovagene is a clinical-stage, oncology therape...

    Filing Type:    PU
    Retrophin, Inc.

    Retrophin, Inc.

    We are a biopharmaceutical company focused on developing our pipeline featuring sp...

    We are a biopharmaceutical company focused on d...

    Filing Type:    PU
    Tenax Therapeutics, Inc.

    Tenax Therapeutics, Inc.

    Tenax Therapeutics is focused on developing and commercializing pharmaceutical pro...

    Tenax Therapeutics is focused on developing and...

    Filing Type:    PU
    PlantPharm BioMed, Ltd.

    PlantPharm BioMed, Ltd.

    We are a global frontrunner in making oral vaccines a reality. We’ve created a p...

    We are a global frontrunner in making oral vacc...

    Amount Raised:    $0.00
    Fundraising Status:    EC
    Filing Type:    CF
    VBI Vaccines, Inc.

    VBI Vaccines, Inc.

    VBI Vaccines Inc. (Nasdaq: VBIV) is a commercial-stage biopharmaceutical company d...

    VBI Vaccines Inc. (Nasdaq: VBIV) is a commercia...

    Filing Type:    PU
    Assembly Biosciences, Inc.

    Assembly Biosciences, Inc.

    Assembly Biosciences is advancing a new class of oral therapeutics for the treatme...

    Assembly Biosciences is advancing a new class o...

    Filing Type:    PU
    Benitec Biopharma Limited

    Benitec Biopharma Limited

    Benitec is a biotechnology company developing a proprietary therapeutic technology...

    Benitec is a biotechnology company developing a...

    Filing Type:    PU
    ©2025 National Investor Network. All Rights Reserved.